Component

Lactobacillus johnsonii NCC 533

Lactobacillus johnsonii NCC 533

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. L. johnsonii NCC 533 hydrolyzed RA completely in the tested incubation and up to 99% in the GI model.

    Lactobacillus johnsonii NCC 533 → Caffeic acid Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Indexed primary abstract/metadata only; unextracted doses, figures and methods remain unknown.
    experimental_model
    Bacterial preparation 25 mg/mL; RA 5 mg/mL; pH 7, 37 °C, 2 h for incubation.
    interpretation_status
    Recorded from source with stated access limits; ungraded, not independent replication.
    limitations
    Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
    nutrient_topic
    Rosmarinic acid collection; exact intervention and molecular form govern interpretation. · Rosmarinic acid
    plain_language
    L. johnsonii NCC 533 hydrolyzed RA completely in the tested incubation and up to 99% in the GI model.
    primary_references
    Hydrolysis of rosmarinic acid from rosemary extract with esterases and Lactobacillus johnsonii in vitro and in a gastrointestinal model. | https://pubmed.ncbi.nlm.nih.gov/19658402/ | https://doi.org/10.1021/jf9014262
    source_locator
    Reviewed reference ra-bacterial-hydrolysis; In-vitro/GI-model finding, not a human-colon mass balance.

    Rosmarinic acid: detailed mechanisms of action (reviewed 10 October 2026) · lines 85–91

    AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · Bacterial preparation 25 mg/mL; RA 5 mg/mL; pH 7, 37 °C, 2 h for incubation. · Recorded from source · Recorded from source

    ### ra-bacterial-hydrolysis L. johnsonii NCC 533 hydrolyzed RA completely in the tested incubation and up to 99% in the GI model. In-vitro/GI-model finding, not a human-colon mass balance. Model and exposure: Bacterial preparation 25 mg/mL; RA 5 mg/mL; pH 7, 37 °C, 2 h for incubation. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Hydrolysis of rosmarinic acid from rosemary extract with esterases and Lactobacillus johnsonii in vitro and in a gastrointestinal model. | 2009 | https://pubmed.ncbi.nlm.nih.gov/19658402/ | https://doi.org/10.1021/jf9014262 | Access: Indexed primary abstract/metadata only; unextracted doses, figures and methods remain unknown.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.